Skip to Main Content

In a boost for Allergan (AGN), the U.S. International Trade Commission agreed to investigate a pair of rival companies for allegedly stealing trade secrets for a new version of its medicine.

In a complaint filed last month, Allergan contended a former employee at Medytox, which has a deal to supply the drug maker with a newer wrinkle-smoothing treatment that is still being tested, stole detailed information and provided the material to Daewoong Pharmaceuticals. Allergan took this step just as Daewoong and Evolus won regulatory approval to sell Jeuveau, a Botox competitor.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED